New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 18, 2012
07:42 EDTAFFYAffymax shares should be bought on weakness, says Piper Jaffray
Piper Jaffray notes the U.S. Government Accountability Office, or GAO, published a report on December 7 recommending that Congress require the Department of Health and Human Services to rebase the End Stage Renal Disease, or ESRD, bundle as Erythropoiesis-Stimulating Agent utilization declined 23% from 2007 to 2011, the year on which the bundle is based. Piper believes a reduction in the bundle is increasingly likely and that dialysis providers will likely require additional discounts from drug manufacturers. The firm thinks this could lead to volatility in shares of Affymax, and recommends buying the stock on weakness.
News For AFFY From The Last 14 Days
Check below for free stories on AFFY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 17, 2014
12:59 EDTAFFYAffymax to host special shareholder meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use